We are live on ! Find out more

GRDN

Guardian Pharmacy Services

GRDN

Market cap $2.36B

37.33 USD

-0.15

0.4%

At close Updated Aug 27, 4:00 PM EDT

1 day

-0.4%

5 days

-0.59%

1 month

-9.96%

3 months

-4.58%

6 months

11.4%

Year to date

26.41%

1 year

44.91%

5 years

133.31%

10 years

133.31%

About: Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.

Employees: 3,600

Healthcare Medical Care Facilities

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 36.4%

Neutral 63.6%

Negative 0%

Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference, on Tuesday, September 15, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 2:25 p.m. Central Standard Time that same day. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation accessible through Guardian Pharmacy.

Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services NYSE: GRDN reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it continued to offset profitability pressure from Inflation Reduction Act-related drug pricing reductions.

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript

Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript

Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates

Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.23 per share a year ago.

Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates

Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2026. The Company also raised its full-year guidance. Second Quarter Financial Results Revenue of $351.8 million, up 2% year-over-year. Residents served ended the quarter at approximately 210,000, up 8% year-over-year. Net Income of $22.1 million, inclusive of an $8.5 m.

Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance

Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United.

Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call

Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia.

Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts

Zacks Investment Research

Bet on Winning DuPont Analysis & Pick 5 Top Stocks

Do you have more faith in DuPont analysis than in simple ROE calculation? Tap CASY, ECG, GRDN, EXPD and MAMA for gains.

Bet on Winning DuPont Analysis & Pick 5 Top Stocks

Zacks Investment Research

Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?

Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?

Guardian Pharmacy Services, Inc. Announces Leadership Transitions

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of July 1, 2026. Upon Mr. Forbes's retirement, David Morris, currently Executive Vice President and Chief Financial Officer of Guardian will assume the role of Chief Operating Officer. In connection with Mr. Morris' new role, Will Mudd, Senior Vice President, Finance, has b.

Guardian Pharmacy Services, Inc. Announces Leadership Transitions

See News Rankings

Price charts implemented using Lightweight Charts™